Emzadirib
Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1[1].
Product Specifications
CAS Number
[2301085-04-9]
Product Name Alternative
CYT-0851; RAD51-IN-2
UNSPSC
12352005
Target
RAD51
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emzadirib.html
Purity
99.63
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(OC(N[C@H]1CC[C@H](C2=NC=C(C3=CC=C(NC(OC(C)C)=O)C=C3S(=O)(NC(C)(C)C)=O)S2)CC1)=O)C
Molecular Formula
C27H40N4O6S2
Molecular Weight
580.76
References & Citations
[1]Alfredo C. Castro, et al. Rad51 inhibitors. WO2019/051465A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
131722-ML405 100 µL
PPP2R5C (KIAA0044, Serine/Threonine-protein Phosphatase 2A 56kD Regulatory Subunit gamma Isoform, PP2A B Subunit Isoform B'-gamma, PP2A B Subunit Isoform B56-gamma, PP2A B Subunit Isoform PR61-gamma, PP2A B Subunit Isoform R5-gamma, Renal Carcinoma Antigen NY-REN-29, MGC23064) (MaxLight 405) discontinued
Ask
View Details